Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Will Revenue Growth Support GoPro's (GPRO) Q4 Earnings?

Published 02/03/2019, 09:50 PM
Updated 07/09/2023, 06:31 AM

GoPro, Inc. (NASDAQ:GPRO) is scheduled to report fourth-quarter 2018 financial results after the closing bell on Feb 6. In the last reported quarter, the company delivered a positive earnings surprise of 42.9%.

The action video camera maker is likely to report higher revenues in the to-be-reported quarter on the back of better-than-expected demand for its cameras — particularly, HERO7 Black. It is also likely to benefit from its continuous efforts on cost management. Whether this can result into an earnings beat remains to be seen.

Let’s find out how things are shaping up prior to the announcement.

Factors at Play

During the fourth quarter, GoPro announced the global availability of its HERO7 line of cameras. Notably, HERO7 Black — the company’s flagship camera — witnessed record levels of social engagement at launch and achieved the highest post-launch sell-through of any new camera in the history of the company.

Furthermore, the company announced that its best-selling $399 HERO7 Black has garnered a number of industry awards, highlighting the product’s state-of-the-art features. Its present cash cow received innovation awards from CES, CHIP, PCMag and Popular Science, among many others. HERO7 Black also received Editor’s Choice Awards from publications around the world including Mashable, Wired, Digital Photo, Kaden Hihyo and Xataka, and Fusion. Such international momentum and overwhelming positive reviews have helped to augment the company’s traction in camera market, translating into top-line growth.

During the quarter, GoPro announced its plan to move the production of most of its U.S.-bound cameras out of China by the summer of 2019 to counter the potential impact of any new tariffs in the wake of the ongoing Sino-American trade war. However, cameras bound for other countries will continue to be produced in China. Such a diversified approach should help the company to expand its business, irrespective of tariff implications. Although GoPro’s manufacturing partner provides facilities, the company owns its production equipment and therefore expects to make this move at a relatively low cost. With intensifying competition, GoPro is trying to drive demand for its cameras. It also aims to maintain its competitively priced product line up in order to increase market share globally.

For the fourth quarter, the Zacks Consensus Estimate for total revenues stands at $376 million. The company reported $335 million in the year-earlier quarter. Adjusted earnings per share are pegged at 26 cents. The company reported a loss of 30 cents per share a year ago.

What Our Model Says

Our proven model shows that GoPro is likely to beat earnings this quarter as it possesses both the two key components. A stock needs to have both a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) for this to happen. This is exactly the case here as you will see below:

Earnings ESP: GoPro’s Earnings ESP, which represents the difference between the Most Accurate Estimate and the Zacks Consensus Estimate, is +5.47% as the former is pegged at 27 cents and the latter at 26 cents. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.

GoPro, Inc. Price and EPS Surprise

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Zacks Rank: GoPro currently has a Zacks Rank #3. This increases the predictive power of ESP and makes us reasonably confident of an earnings beat.

Note that we caution against stocks with a Zacks Rank #4 or 5 (Sell-rated) going into the earnings announcement, especially when the company is seeing a negative estimate revisions momentum.

Other Stocks to Consider

Here are some other companies that you may want to consider, as our model shows that these have the right combination of elements to post an earnings beat this quarter:

Constellation Pharmaceuticals, Inc. (NASDAQ:CNST) has an Earnings ESP of +9.72% and a Zacks Rank #1. You can see the complete list of today’s Zacks #1 Rank stocks here.

Ameren Corporation (NYSE:AEE) has an Earnings ESP of +1.68% and a Zacks Rank #1.

ALLETE, Inc. (NYSE:ALE) has an Earnings ESP of +5.26% and a Zacks Rank #2.

Today's Best Stocks from Zacks

Would you like to see the updated picks from our best market-beating strategies? From 2017 through 2018, while the S&P 500 gained +15.8%, five of our screens returned +38.0%, +61.3%, +61.6%, +68.1%, and +98.3%.

This outperformance has not just been a recent phenomenon. From 2000 – 2018, while the S&P averaged +4.8% per year, our top strategies averaged up to +56.2% per year.

See their latest picks free >>



Allete, Inc. (ALE): Free Stock Analysis Report

Ameren Corporation (AEE): Get Free Report

GoPro, Inc. (GPRO): Free Stock Analysis Report

Constellation Pharmaceuticals, Inc. (CNST): Free Stock Analysis Report
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .


Original post

Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.